Cellular imaging is a technology used to detect and analyze organelles and macromolecules with the help of microscopy and computer programming. It also helps in measuring properties of cells including shape, size and protein presence. Cellular imaging also helps in knowing biomolecules nature. Confocal laser scanning microscopy, fluroscence resonance energy transfer and multiphoton are some of the advanced cellular imaging techniques which helps in understanding molecular and functional systems in the cell. Hospitals, academic institutions, pharmaceuticals and biotechnology companies uses cellular imaging systems as an important tool for drug discovery, research and diagnosis. Cellular imaging also helps in generating high throughput mode to discover the biomarkers and drug target candidates. Microscopic and macroscopic techniques are two types of intravital cellular imaging technologies.
Highlights
The global Cellular Imaging market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest market for cellular imaging followed by Europe due to increasing incidence of cancer and rising number of R&D activities. Asia is expected to experience high growth rate in next few years due to rising government investments for cell based research activities. In addition, growing demand for outsourcing of drug discovery services is also fuelling the growth of cellular imaging market in Asia.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cellular Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cellular Imaging.
The Cellular Imaging market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cellular Imaging market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cellular Imaging companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Agilent Technologies
Beckton
Dickinson
Danaher
Olympus
GE Healthcare
Promega
Thermo Fisher Scientific
Segment by Type
Microscopic Techniques
Macroscopic Techniques
Segment by Application
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Contract Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cellular Imaging companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Cellular Imaging Âé¶¹Ô´´ Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Microscopic Techniques
1.2.3 Macroscopic Techniques
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Cellular Imaging Âé¶¹Ô´´ Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Academic & Research Institutes
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Hospitals & Diagnostic Centers
1.3.5 Contract Research Organizations
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cellular Imaging Âé¶¹Ô´´ Perspective (2018-2029)
2.2 Cellular Imaging Growth Trends by Region
2.2.1 Global Cellular Imaging Âé¶¹Ô´´ Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cellular Imaging Historic Âé¶¹Ô´´ Size by Region (2018-2023)
2.2.3 Cellular Imaging Forecasted Âé¶¹Ô´´ Size by Region (2024-2029)
2.3 Cellular Imaging Âé¶¹Ô´´ Dynamics
2.3.1 Cellular Imaging Industry Trends
2.3.2 Cellular Imaging Âé¶¹Ô´´ Drivers
2.3.3 Cellular Imaging Âé¶¹Ô´´ Challenges
2.3.4 Cellular Imaging Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cellular Imaging Players by Revenue
3.1.1 Global Top Cellular Imaging Players by Revenue (2018-2023)
3.1.2 Global Cellular Imaging Revenue Âé¶¹Ô´´ Share by Players (2018-2023)
3.2 Global Cellular Imaging Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cellular Imaging Revenue
3.4 Global Cellular Imaging Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Cellular Imaging Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cellular Imaging Revenue in 2022
3.5 Cellular Imaging Key Players Head office and Area Served
3.6 Key Players Cellular Imaging Product Solution and Service
3.7 Date of Enter into Cellular Imaging Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Cellular Imaging Breakdown Data by Type
4.1 Global Cellular Imaging Historic Âé¶¹Ô´´ Size by Type (2018-2023)
4.2 Global Cellular Imaging Forecasted Âé¶¹Ô´´ Size by Type (2024-2029)
5 Cellular Imaging Breakdown Data by Application
5.1 Global Cellular Imaging Historic Âé¶¹Ô´´ Size by Application (2018-2023)
5.2 Global Cellular Imaging Forecasted Âé¶¹Ô´´ Size by Application (2024-2029)
6 North America
6.1 North America Cellular Imaging Âé¶¹Ô´´ Size (2018-2029)
6.2 North America Cellular Imaging Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cellular Imaging Âé¶¹Ô´´ Size by Country (2018-2023)
6.4 North America Cellular Imaging Âé¶¹Ô´´ Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cellular Imaging Âé¶¹Ô´´ Size (2018-2029)
7.2 Europe Cellular Imaging Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cellular Imaging Âé¶¹Ô´´ Size by Country (2018-2023)
7.4 Europe Cellular Imaging Âé¶¹Ô´´ Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cellular Imaging Âé¶¹Ô´´ Size (2018-2029)
8.2 Asia-Pacific Cellular Imaging Âé¶¹Ô´´ Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cellular Imaging Âé¶¹Ô´´ Size by Region (2018-2023)
8.4 Asia-Pacific Cellular Imaging Âé¶¹Ô´´ Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cellular Imaging Âé¶¹Ô´´ Size (2018-2029)
9.2 Latin America Cellular Imaging Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cellular Imaging Âé¶¹Ô´´ Size by Country (2018-2023)
9.4 Latin America Cellular Imaging Âé¶¹Ô´´ Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cellular Imaging Âé¶¹Ô´´ Size (2018-2029)
10.2 Middle East & Africa Cellular Imaging Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cellular Imaging Âé¶¹Ô´´ Size by Country (2018-2023)
10.4 Middle East & Africa Cellular Imaging Âé¶¹Ô´´ Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Cellular Imaging Introduction
11.1.4 Agilent Technologies Revenue in Cellular Imaging Business (2018-2023)
11.1.5 Agilent Technologies Recent Development
11.2 Beckton
11.2.1 Beckton Company Detail
11.2.2 Beckton Business Overview
11.2.3 Beckton Cellular Imaging Introduction
11.2.4 Beckton Revenue in Cellular Imaging Business (2018-2023)
11.2.5 Beckton Recent Development
11.3 Dickinson
11.3.1 Dickinson Company Detail
11.3.2 Dickinson Business Overview
11.3.3 Dickinson Cellular Imaging Introduction
11.3.4 Dickinson Revenue in Cellular Imaging Business (2018-2023)
11.3.5 Dickinson Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher Cellular Imaging Introduction
11.4.4 Danaher Revenue in Cellular Imaging Business (2018-2023)
11.4.5 Danaher Recent Development
11.5 Olympus
11.5.1 Olympus Company Detail
11.5.2 Olympus Business Overview
11.5.3 Olympus Cellular Imaging Introduction
11.5.4 Olympus Revenue in Cellular Imaging Business (2018-2023)
11.5.5 Olympus Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Detail
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Cellular Imaging Introduction
11.6.4 GE Healthcare Revenue in Cellular Imaging Business (2018-2023)
11.6.5 GE Healthcare Recent Development
11.7 Promega
11.7.1 Promega Company Detail
11.7.2 Promega Business Overview
11.7.3 Promega Cellular Imaging Introduction
11.7.4 Promega Revenue in Cellular Imaging Business (2018-2023)
11.7.5 Promega Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Detail
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Cellular Imaging Introduction
11.8.4 Thermo Fisher Scientific Revenue in Cellular Imaging Business (2018-2023)
11.8.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Agilent Technologies
Beckton
Dickinson
Danaher
Olympus
GE Healthcare
Promega
Thermo Fisher Scientific
Ìý
Ìý
*If Applicable.